Product NDC: | 55253-601 |
Proprietary Name: | tiagabine hydrochloride |
Non Proprietary Name: | tiagabine hydrochloride |
Active Ingredient(s): | 4 mg/1 & nbsp; tiagabine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55253-601 |
Labeler Name: | CIMA Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020646 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20121226 |
Package NDC: | 55253-601-30 |
Package Description: | 30 TABLET in 1 BOTTLE (55253-601-30) |
NDC Code | 55253-601-30 |
Proprietary Name | tiagabine hydrochloride |
Package Description | 30 TABLET in 1 BOTTLE (55253-601-30) |
Product NDC | 55253-601 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | tiagabine hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20121226 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | CIMA Laboratories, Inc. |
Substance Name | TIAGABINE HYDROCHLORIDE |
Strength Number | 4 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |